Osimertinib and Triptorelin: Interaction Details
- Osimertinib
- Tagrisso
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Osimertinib and Triptorelin interaction:
Triptorelin
We don't have a drug information page for Triptorelin yet. Have a question about Triptorelin? Ask a pharmacist, free →
What Happens When You Take Osimertinib With Triptorelin
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
If at all possible, do not use this drug together with agents that are known to prolong the and carry a recognized risk of . When combined use cannot be avoided, monitoring should be performed at regular intervals.1
The Osimertinib and Triptorelin Interaction, Explained
Both osimertinib (Tagrisso), a lung cancer medicine, and triptorelin, a hormone-lowering medicine, can affect the heart's electrical rhythm. Each can lengthen a measurement on an called the . Taken together, the effect could add up. This is a theoretical concern, meaning it is based on how the drugs work rather than on proven cases. Rarely, a very long QT interval can cause a dangerous irregular heartbeat.
Do not stop or change either medicine on your own. Your care team can check your heart rhythm with an ECG from time to time and manage this safely. Tell them about any fainting, dizziness, or racing or fluttering heartbeat.
Interaction: () with osimertinib and triptorelin (GnRH , androgen deprivation therapy). Evidence is theoretical. Severity on file: major. Onset unspecified.
- Direction: increased risk of QTc prolongation; no PK change is implied.
- Management: avoid combining QT-prolonging agents with known TdP risk where possible. If combined, evaluate periodically.
- Also consider: baseline , electrolytes (K, Mg, Ca), other QT-prolonging drugs, and cardiac history or risk factors.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Osimertinib and Triptorelin Interact
The likely mechanism
How to Manage the Osimertinib and Triptorelin Interaction
Your care team can manage this combination, usually by checking your heart rhythm.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Your team may evaluate your periodically and may monitor you more closely.
- If possible, your team may avoid adding other medicines that affect the , or may consider alternatives.
- Tell your pharmacist or doctor about all your medicines, including over-the-counter ones and supplements.
- Report fainting, severe dizziness, or a pounding or irregular heartbeat right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Osimertinib or Triptorelin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Osimertinib and Triptorelin: Common Questions
How serious is the Osimertinib and Triptorelin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Osimertinib and Triptorelin interaction managed?
Your care team can manage this combination, usually by checking your heart rhythm. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your team may evaluate your periodically and may monitor you more closely. If possible, your team may avoid adding other medicines that affect the , or may consider alternatives. Tell your pharmacist or doctor about a… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Osimertinib and Triptorelin Interaction
Ask in your own words about taking Osimertinib and Triptorelin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: TAGRISSO(R) oral tablets, osimertinib oral tablets. AstraZeneca Pharmaceuticals LP (per manufacturer), Wilmington, DE, 2018. DailyMed
Other Serious Interactions of Osimertinib and Triptorelin
Also serious with Osimertinib
- ColchicineContraindicated
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PimozideContraindicated
Also serious with Triptorelin
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.